• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于结构的 HIV 疫苗设计面临的挑战。

Challenges for structure-based HIV vaccine design.

机构信息

Department of Biochemistry, University of Washington, Seattle, USA.

出版信息

Curr Opin HIV AIDS. 2009 Sep;4(5):431-40. doi: 10.1097/COH.0b013e32832e6184.

DOI:10.1097/COH.0b013e32832e6184
PMID:20048708
Abstract

PURPOSE OF REVIEW

We review structural information on the native HIV envelope trimer and the known epitopes for broadly neutralizing antibodies and discuss how this structural information should guide the design of more effective immunogens.

RECENT FINDINGS

Recent epitope mapping of HIV-positive sera demonstrates that the immune system is able to mount a potent and broadly neutralizing antibody response against conserved elements of the HIV envelope. The structure of trimeric envelope spikes on intact HIV-1 virions (the target of neutralizing antibodies) was determined at low resolution using cryo-electron tomography. Fitting high-resolution crystal structures of monomeric gp120 complexed with different neutralizing ligands into the cryo-electron density maps provides useful models for the native virion trimer and for mechanisms of neutralization.

SUMMARY

So far, all attempts to elicit broadly neutralizing antibodies against HIV by immunization have failed. Recent structural information on the virion-associated HIV envelope spike and of the precise interaction of broadly neutralizing mAbs with their epitopes clarifies the steric and geometric constraints faced by antibodies targeting conserved HIV epitopes. Implications for vaccine design are discussed.

摘要

目的综述

我们回顾了天然 HIV 包膜三聚体的结构信息和已知的广谱中和抗体表位,并讨论了这些结构信息应如何指导更有效免疫原的设计。

最近的发现

最近对 HIV 阳性血清的表位作图表明,免疫系统能够针对 HIV 包膜的保守元件产生强大的广谱中和抗体反应。使用冷冻电镜断层扫描术以低分辨率测定了完整 HIV-1 病毒颗粒(中和抗体的靶标)上三聚体包膜刺突的结构。将高分辨率的单体 gp120 与不同中和配体复合物的晶体结构拟合到冷冻电镜密度图中,为天然病毒三聚体和中和机制提供了有用的模型。

总结

到目前为止,通过免疫接种来诱导针对 HIV 的广谱中和抗体的所有尝试都失败了。最近关于病毒相关 HIV 包膜刺突的结构信息以及广谱中和 mAb 与其表位的确切相互作用,阐明了针对保守 HIV 表位的抗体所面临的空间和几何限制。讨论了对疫苗设计的影响。

相似文献

1
Challenges for structure-based HIV vaccine design.基于结构的 HIV 疫苗设计面临的挑战。
Curr Opin HIV AIDS. 2009 Sep;4(5):431-40. doi: 10.1097/COH.0b013e32832e6184.
2
Immunogenic Display of Purified Chemically Cross-Linked HIV-1 Spikes.纯化的化学交联HIV-1刺突的免疫原性展示
J Virol. 2015 Jul;89(13):6725-45. doi: 10.1128/JVI.03738-14. Epub 2015 Apr 15.
3
Broadly neutralizing antibodies against HIV-1: templates for a vaccine.广谱中和抗体抗 HIV-1:疫苗的模板。
Virology. 2013 Jan 5;435(1):46-56. doi: 10.1016/j.virol.2012.10.004.
4
Conformational Epitope-Specific Broadly Neutralizing Plasma Antibodies Obtained from an HIV-1 Clade C-Infected Elite Neutralizer Mediate Autologous Virus Escape through Mutations in the V1 Loop.从一名感染HIV-1 C亚型的精英中和者体内获得的构象表位特异性广泛中和性血浆抗体通过V1环区的突变介导自体病毒逃逸。
J Virol. 2016 Jan 13;90(7):3446-57. doi: 10.1128/JVI.03090-15.
5
HIV-1 Envgp140 trimers elicit neutralizing antibodies without efficient induction of conformational antibodies.HIV-1包膜糖蛋白gp140三聚体可引发中和抗体,但无法有效诱导构象依赖性抗体。
Vaccine. 2006 Jun 29;24(26):5442-51. doi: 10.1016/j.vaccine.2006.03.063. Epub 2006 Apr 3.
6
Immunogenicity of a Prefusion HIV-1 Envelope Trimer in Complex with a Quaternary-Structure-Specific Antibody.预融合HIV-1包膜三聚体与四级结构特异性抗体复合物的免疫原性
J Virol. 2015 Dec 30;90(6):2740-55. doi: 10.1128/JVI.02380-15.
7
Potent Induction of Envelope-Specific Antibody Responses by Virus-Like Particle Immunogens Based on HIV-1 Envelopes from Patients with Early Broadly Neutralizing Responses.基于具有早期广泛中和反应的患者的 HIV-1 包膜的病毒样颗粒免疫原可有效诱导包膜特异性抗体应答。
J Virol. 2022 Jan 12;96(1):e0134321. doi: 10.1128/JVI.01343-21. Epub 2021 Oct 20.
8
Murine Antibody Responses to Cleaved Soluble HIV-1 Envelope Trimers Are Highly Restricted in Specificity.小鼠对裂解的可溶性HIV-1包膜三聚体的抗体反应在特异性上受到高度限制。
J Virol. 2015 Oct;89(20):10383-98. doi: 10.1128/JVI.01653-15. Epub 2015 Aug 5.
9
GP120: target for neutralizing HIV-1 antibodies.糖蛋白120:HIV-1中和抗体的靶点。
Annu Rev Immunol. 2006;24:739-69. doi: 10.1146/annurev.immunol.24.021605.090557.
10
The antigenic structure of the HIV gp120 envelope glycoprotein.人类免疫缺陷病毒gp120包膜糖蛋白的抗原结构。
Nature. 1998 Jun 18;393(6686):705-11. doi: 10.1038/31514.

引用本文的文献

1
Structural insights into VRC01-class bnAb precursors with diverse light chains elicited in the IAVI G001 human vaccine trial.在IAVI G001人体疫苗试验中引发的具有不同轻链的VRC01类广谱中和抗体前体的结构见解。
Proc Natl Acad Sci U S A. 2025 Aug 19;122(33):e2510163122. doi: 10.1073/pnas.2510163122. Epub 2025 Aug 11.
2
Structural insights into VRC01-class bnAb precursors with diverse light chains elicited in the IAVI G001 human vaccine trial.在IAVI G001人体疫苗试验中引发的具有不同轻链的VRC01类广谱中和抗体前体的结构见解。
bioRxiv. 2025 May 27:2025.05.22.655646. doi: 10.1101/2025.05.22.655646.
3
Enhancing broadly neutralising antibody suppression of HIV by immune modulation and vaccination.
通过免疫调节和疫苗接种增强广泛中和抗体对 HIV 的抑制作用。
Front Immunol. 2024 Nov 7;15:1478703. doi: 10.3389/fimmu.2024.1478703. eCollection 2024.
4
Structures and immune recognition of Env trimers from two Asia prevalent HIV-1 CRFs.两种亚洲流行的 HIV-1 型 CRF 的 Env 三聚体的结构和免疫识别。
Nat Commun. 2023 Aug 4;14(1):4676. doi: 10.1038/s41467-023-40321-x.
5
Extended antibody-framework-to-antigen distance observed exclusively with broad HIV-1-neutralizing antibodies recognizing glycan-dense surfaces.仅观察到具有广泛识别糖基密集表面的 HIV-1 中和抗体的抗体框架到抗原的延长距离。
Nat Commun. 2021 Nov 9;12(1):6470. doi: 10.1038/s41467-021-26579-z.
6
Second career of a biosynthetic enzyme: Lumazine synthase as a virus-like nanoparticle in vaccine development.生物合成酶的第二重使命:在疫苗研发中作为类病毒纳米颗粒的核黄素合酶
Biotechnol Rep (Amst). 2020 Jul 6;27:e00494. doi: 10.1016/j.btre.2020.e00494. eCollection 2020 Sep.
7
Induction of cross-reactive HIV-1 specific antibody responses by engineered V1V2 immunogens with reduced conformational plasticity.通过降低构象灵活性的工程化 V1V2 免疫原诱导交叉反应性 HIV-1 特异性抗体应答。
Vaccine. 2020 Apr 16;38(18):3436-3446. doi: 10.1016/j.vaccine.2020.03.010. Epub 2020 Mar 17.
8
Effects of a remote mutation from the contact paratope on the structure of CDR-H3 in the anti-HIV neutralizing antibody PG16.远程突变对 HIV 中和抗体 PG16 中 CDR-H3 结构的影响。
Sci Rep. 2019 Dec 27;9(1):19840. doi: 10.1038/s41598-019-56154-y.
9
Artificial Anti-HIV-1 Immunogen Comprising Epitopes of Broadly Neutralizing Antibodies 2F5, 10E8, and a Peptide Mimic of VRC01 Discontinuous Epitope.包含广泛中和抗体2F5、10E8表位以及VRC01不连续表位肽模拟物的人工抗HIV-1免疫原
Vaccines (Basel). 2019 Aug 6;7(3):83. doi: 10.3390/vaccines7030083.
10
Induction of Fc-Mediated Effector Functions Against a Stabilized Inner Domain of HIV-1 gp120 Designed to Selectively Harbor the A32 Epitope Region.诱导针对 HIV-1 gp120 稳定内部结构域的 Fc 介导的效应功能,该结构域设计用于选择性容纳 A32 表位区域。
Front Immunol. 2019 Apr 2;10:677. doi: 10.3389/fimmu.2019.00677. eCollection 2019.